Search

Elanco Animal Health Inc

Cerrado

SectorSanidad

23.66 5.16

Resumen

Variación precio

24h

Actual

Mínimo

22.49

Máximo

23.67

Métricas clave

By Trading Economics

Ingresos

-3M

54M

Ventas

-3M

1.4B

P/B

Media del Sector

372.714

57.002

BPA

0.34

Margen de beneficios

3.947

Empleados

9,400

EBITDA

-42M

274M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+39.18% upside

Dividendos

By Acuity

Próximas Ganancias

4 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.7B

11B

Apertura anterior

18.5

Cierre anterior

23.66

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

117 / 340 Clasificación en Healthcare

Elanco Animal Health Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ago 2026, 23:36 UTC

Elanco Animal Health shares declined in after-market trading, remaining below the 20-day moving average amid concerns over a surprising drop in U.S. retail sales.

13 ago 2026, 20:06 UTC

Elanco Animal Health Inc shares are higher today amid a broader market uptrend. The stock remains below its 20-day moving average.

12 ago 2026, 19:51 UTC

Elanco Animal Health shares are declining today, despite high trading volume. No specific news was identified to explain the downward movement.

11 ago 2026, 19:36 UTC

News

Elanco Animal Health receives FDA Emergency Use Authorization for CLiK Extra wound spray to combat New World screwworm infestations, boosting shares during Tuesday's session.

10 ago 2026, 23:06 UTC

Elanco Animal Health shares are higher in after-market trading, following notable volatility during the session. The stock remains below its 20-day moving average.

7 ago 2026, 23:36 UTC

Elanco Animal Health shares are higher in after-market trading, following a session spike despite no specific company news identified.

6 ago 2026, 23:36 UTC

Elanco Animal Health Inc shares are higher in after-market hours. No specific news was identified to explain this movement, which shows routine trading.

5 ago 2026, 19:52 UTC

News

Elanco Animal Health reported second-quarter revenue of $1.368 billion and raised its full-year adjusted EPS guidance to between $1.10 and $1.16. Shares are higher.

4 ago 2026, 23:01 UTC

Elanco Animal Health Inc shares are higher in after-market hours, recovering from three days of declines amid broader market optimism and easing oil prices.

3 ago 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 jul 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 jul 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 jul 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 jul 2026, 18:26 UTC

Correlated Moves
News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 jul 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 jul 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 jul 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 jul 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 jul 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 jul 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Comparación entre iguales

Cambio de precio

Elanco Animal Health Inc previsión

Precio Objetivo

By TipRanks

39.18% repunte

Estimación a 12 Meses

Media 31.33 USD  39.18%

Máximo 34 USD

Mínimo 26 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Elanco Animal Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

12 ratings

11

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

117 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat